Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Ramiz N Hamid"'
Publikováno v:
Journal of Dermatological Treatment. 33:2707-2710
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2793cf2c6e880844f1760be7721cc6
https://doi.org/10.1080/09546634.2022.2110360
https://doi.org/10.1080/09546634.2022.2110360
Publikováno v:
JAAD Case Reports
JAAD Case Reports, Vol 17, Iss, Pp 12-17 (2021)
JAAD Case Reports, Vol 17, Iss, Pp 12-17 (2021)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bc2791b471104662fe971aec784d282
https://doi.org/10.1016/j.jdcr.2021.09.004
https://doi.org/10.1016/j.jdcr.2021.09.004
Publikováno v:
Dermatologic Surgery. 48:1000-1001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19c607375473deac2429e7a33dbcb842
https://doi.org/10.1097/dss.0000000000003536
https://doi.org/10.1097/dss.0000000000003536
Autor:
Zeynep M Akkurt, Ramiz N Hamid
Publikováno v:
Dermatologic Clinics. 37:607-613
Cutaneous findings that appear in childhood may be the first sign of a hereditary tumor syndrome. Early detection of genodermatoses allows the patient and at-risk family members to be screened for associated malignancies. This article provides a brie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35eff8e3993d16207c22d32b8b625fa2
https://doi.org/10.1016/j.det.2019.05.016
https://doi.org/10.1016/j.det.2019.05.016
Publikováno v:
Dermatologic Surgery. 45:1035-1041
Background There have been recent claims of overdiagnosis and unnecessary treatment in dermatology. One potential manifestation of overutilization would be providers who perform numerous biopsies per patient. Objective To identify the frequency of sk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe354acee001a9a3bd87efb5c6d2b3c6
https://doi.org/10.1097/dss.0000000000001763
https://doi.org/10.1097/dss.0000000000001763
Publikováno v:
Cutis. 107(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25d33ec7f3427dcfcc93e54fda26d1f8
https://pubmed.ncbi.nlm.nih.gov/33891836
https://pubmed.ncbi.nlm.nih.gov/33891836
Autor:
Megan Newsom, Matthew L. Hrin, Lindsay C. Strowd, Joseph L. Jorizzo, Christine S. Ahn, Ramiz N Hamid, Steven R. Feldman
Publikováno v:
Newsom, M, Hrin, M L, Hamid, R N, Strowd, L C, Ahn, C, Jorizzo, J L & Feldman, S R 2021, ' Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab ', Dermatology Online Journal, vol. 27, no. 1, 18 . https://doi.org/10.5070/D3271052041
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6483d9cd48e4853957d47f3751580f
https://doi.org/10.5070/d3271052041
https://doi.org/10.5070/d3271052041
Publikováno v:
Journal of drugs in dermatology : JDD. 19(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::7c8b14a6611a25d3a5425d2f85f27672
https://pubmed.ncbi.nlm.nih.gov/32401458
https://pubmed.ncbi.nlm.nih.gov/32401458
Publikováno v:
Cutis. 102(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::557dd8231a6dc54225d2581d236f3658
https://pubmed.ncbi.nlm.nih.gov/30657803
https://pubmed.ncbi.nlm.nih.gov/30657803
Publikováno v:
Journal of Dermatological Treatment. 30:487-488
Neratinib is a tyrosine kinase inhibitor that was FDA-approved for extended adjuvant treatment in adults with human epidermal growth factor receptors-2 (HER-2) positive breast cancer in 2017. Due to the novelty of the drug, there are no current repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c7a67cda9b3bcdd2506e1db5bc763a
https://doi.org/10.1080/09546634.2018.1536253
https://doi.org/10.1080/09546634.2018.1536253